Faruqi & Faruqi, LLP is Investigating Emergent BioSolutions (EBS) on Behalf of its Shareholders

NEW YORK - (NewMediaWire) - June 23, 2021 - Faruqi & Faruqi, LLP, a leading minority and Woman-owned national securities law firm, is investigating potential misconduct at Emergent BioSolutions Inc. (“Emergent BioSolutions” or the “Company”) (NYSE:EBS).

The investigation focuses on whether the Company’s Board of Directors and/or officers breached their fiduciary duties. 

Request more information now by clicking here: www.faruqilaw.com/EBS.  There is no cost or obligation to you.

Take Action

If you currently own Emergent BioSolutions stock, have continuously owned Emergent BioSolutions stock and would like to discuss your legal rights, please visit www.faruqilaw.com/EBS.  You can also contact us by calling Nina Varindani or Christopher M. Lash toll free at (215) 277-5770 (Ext. 1413) or by sending an e-mail to nvarindani@faruqilaw.com or clash@faruqilaw.com.  Faruqi & Faruqi, LLP also encourages anyone with information regarding the Company’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Delaware, Pennsylvania, California and Georgia.

Attorney Advertising.  The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com).  Prior results do not guarantee or predict a similar outcome with respect to any future matter.  We welcome the opportunity to discuss your particular case.  All communications will be treated in a confidential manner.


685 3rd Avenue, 26th Floor

New York, NY 11237

Attn: Nina Varindani


Telephone: (212) 983-9330


1617 JFK Boulevard, Suite 1550

Philadelphia, PA 19103

Attn: Christopher M. Lash


Telephone: (215) 277-5770

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.